VEGF-B cardiac gene therapy with differential expression using the anf-promoter or therapy delay during heart failure development in a pre-clinical model of dilated cardiomyopathy.
Event:
ESC Congress 2016
Topic:
Genetics and gene therapy
Session:
Genetics and gene therapy
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
